2 July 2021Prescribers may need to choose a safe antidepressant in people with CHD. We guide on available options. We do not cover management of complex depression.
21 October 2020Additional information relating to breastfeeding To be used in conjunction with individual drug entries for specific information and guidance. Monamine-oxidase inhibitors (MAOIs) Due to the…
21 October 2019This updated Medicines Q&A provides advice on the risks and suggested strategies for switching between tricyclic (TCA), selective serotonin reuptake inhibitors (SSRI) and related antidepressants.…
10 June 2019This Medicines Q&A evaluates the evidence available on the management of depression in patients with antidepressant-induced hyponatraemia. Summary Most antidepressants are associated with hyponatraemia, with…
Medicine Compliance Aid Stability
ValdoxanServier Laboratories Ltd
Servier Laboratories Ltd
Tablets f/c 25mg
A2 · Amber 2 No stability data is available, the manufacturer does not, or cannot recommend use in CAs but there are no theoretical concerns with the product.
No special precautions for storage
No special precautions for storage.
26 October 2015
Lactation Safety Information
TCA: imipramine/nortriptyline SSRI: paroxetine/sertraline
Very limited published evidence of safety
Low levels anticipated in milk due to the drug’s properties
Monitor infant for drowsiness, poor feeding, irritability/behavioural effects
3 August 2020